about
Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteriaCorrelates of Protection for M Protein-Based Vaccines against Group A StreptococcusStreptococcal pharyngitis in schoolchildren in Bamako, Mali.Essential Genes in the Core Genome of the Human Pathogen Streptococcus pyogenes.Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children.Congenital heart disease and rheumatic heart disease in Africa: recent advances and current prioritiesNovel platform technology for modular mucosal vaccine that protects against streptococcus.Of history, half-truths, and rheumatic fever.Acute rheumatic fever and rheumatic heart disease in resource-limited settings.Invasive streptococcal disease: a review for clinicians.Development of Group A streptococcal vaccines: an unmet global health need.High burden of invasive group A streptococcal disease in the Northern Territory of Australia.Immunological Outcomes of Antibody Binding to Glycans Shared between Microorganisms and Mammals.A Critical Role of Zinc Importer AdcABC in Group A Streptococcus-Host Interactions During Infection and Its Implications for Vaccine Development.The emm-cluster typing system for Group A Streptococcus identifies epidemiologic similarities across the Pacific region.Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity.
P2860
Q26765815-9EC7C5C2-4DC4-4160-BC1D-9DCDBFBDA8DDQ27009175-EDAF5B0D-7DB8-41EA-B737-AC5250AF075FQ30301331-6BFE4F1D-B36F-4B3C-A425-062DA903D8A3Q34044076-6BFF3096-149B-4AA7-8D7B-04AC3B313B0CQ36616151-B8E31A63-514D-400E-9E51-B3729D3259E7Q37267579-04A1C5AE-D265-4325-86DE-E7D765A0684BQ37504796-437CB9CC-D2FC-4014-8F40-8C44A0A940A4Q38315912-57BF5C7E-30F5-4E6D-B080-47F25B79EE9EQ38382463-FE6DF8A0-C9CF-42C0-9FB0-72C6B6ACA0B9Q38553946-B2E323CE-CB6B-4D89-A738-B01863400FDBQ38631048-E9B2C234-F5BE-414D-B4C9-9C8AA2981245Q38918668-742778AD-FC8B-4BF2-AAE7-767DBF81024FQ39013747-187BF8F7-7B35-4166-AD97-9A0696CC82DAQ40179732-D20EE318-C8C1-4931-B5DA-58B3CBD50026Q40202353-F9DEFC5B-E0A1-46D1-B7E3-8FD1A036A328Q41588446-B8DF5ECD-68AC-4FBA-A021-4F63682F4D8E
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Progress toward a global group a streptococcal vaccine.
@en
Progress toward a global group a streptococcal vaccine.
@nl
type
label
Progress toward a global group a streptococcal vaccine.
@en
Progress toward a global group a streptococcal vaccine.
@nl
prefLabel
Progress toward a global group a streptococcal vaccine.
@en
Progress toward a global group a streptococcal vaccine.
@nl
P1476
Progress toward a global group a streptococcal vaccine
@en
P2093
Andrew C Steer
Jonathan R Carapetis
P304
P356
10.1097/INF.0B013E318281DA11
P50
P577
2013-02-01T00:00:00Z